Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

WAYNE, Pa. & NEW YORK--(BUSINESS WIRE)--Aug 4, 2025--

Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804234289/en/

With deep in-house and agency PR experience in the life sciences industry, Heinley is a highly seasoned counselor with a proven record of strategic communications impact across leading global organizations. These include senior leadership roles at Johnson & Johnson, Merck & Co., Inc., and WebMD. Most recently, as Senior Partner in the Finn Partners Global Health Practice, he led client development and engagement for pharmaceutical, biotech, health tech, med tech, health systems, professional societies, and advocacy organizations.

“In today’s fast-moving and complex healthcare environment, Michael has a distinct perspective leading corporate, scientific, marketing, and brand storytelling campaigns that build trust, strengthen reputation, and deliver meaningful business results,” said Laura Liotta, Founder and President of Sam Brown. “In this new role at Sam Brown, Michael will be instrumental in delivering innovative solutions, expanding our services and markets globally, and enabling our integrated teams to help clients adapt and lead in an evolving landscape.”

Throughout his career, Heinley oversaw multiple global pharmaceutical product launches, R&D communications, employee engagement, financial/IR communications, reputation and issues management, CEO and C-suite counsel, and executive thought leadership.

Heinley was named among the industry’s most influential leaders and Mentor of the Year by PM360. He currently serves on the Board of Directors for Donate Life New York State, a statewide nonprofit dedicated to increasing organ and tissue donation.

“I’m thrilled to join the talented team at Sam Brown to help drive the agency’s continued growth and success,” said Heinley. “Under Laura’s leadership, I’ve deeply admired the ‘Sam Brownie’ culture—recognized for building and sustaining enduring client partnerships through strategic expertise, hands-on senior counsel, and integrated creative excellence.”

About Sam Brown Healthcare Communications

For 26 years, Sam Brown has been a leading healthcare-focused corporate, clinical, and commercial communications agency for the life sciences industry. Sam Brown provides broad strategic communications services to a wide range of biotechnology, biopharmaceutical, and venture capital companies whose cutting-edge science and innovation impact human health. For more information, visit www.sambrown.com.

About Blue Matter

Blue Matter is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies from around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels. It has broad therapeutic expertise with a focus on complex markets such as oncology, CNS, and rare diseases. For more information, visit www.bluematter.com.

Michael Heinley

NEW YORK (AP) — A surging stock market and a flurry of deal making padded the profits of Wall Street's two big investment banks, which both saw a double-digit jump in profits in the fourth quarter.

Goldman Sachs's net earnings rose 12% from a year earlier, posting a profit of $4.62 billion, or $14.01 a share. Meanwhile Morgan Stanley said it earned $4.4 billion, or $2.68 per share, compared to a profit of $3.71 billion, or $2.22 per share, compared to a year earlier.

Wall Street has been bolstered by the Trump administration's deregulatory policies, which has led corporations to seek out mergers and acquisitions, as well as the surge of investor interest in artificial intelligence companies and those who stand to benefit from the mass adoption of technologies like ChatGPT.

Fourth-quarter investment fee revenues over at Goldman were up 25% year-over-year and Morgan Stanley saw a 47% jump in revenue in its investment banking division. Both banks said their investment fee backlog, which is a signal of how much deal making is still pending that banks are working on, increased significantly in the fourth quarter.

Goldman and Morgan's results reflect the strong earnings out of the other big banks that reported their results this week. JPMorgan Chase, Bank of America and Citigroup all saw jumps in fourth-quarter profits, but their results were dampened by the ongoing tensions that Wall Street is having with the White House over the issue of the independence of the Federal Reserve and President Donald Trump's interest in capping credit card interest rates at 10%.

Along with a strong investment banking performance, Goldman Sachs also agreed to sell off its Apple Card credit card portfolio to JPMorgan Chase last week, effectively exiting its brief experiment in consumer banking. The bank sold the credit card portfolio at a discount to JPMorgan, a sign of how desperately Goldman wanted to exit the business and put the Apple Card behind it.

This story has been corrected to show that Morgan Stanley's investment banking revenues rose 47%, not 22%.

FILE - Electronic signage is shown at Morgan Stanley headquarters, Thursday, March 4, 2021 in New York. (AP Photo/Mark Lennihan, File)

FILE - In this Dec. 13, 2016, file photo, the logo for Goldman Sachs appears above a trading post on the floor of the New York Stock Exchange. (AP Photo/Richard Drew, File)